SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-17-033491
Filing Date
2017-05-17
Accepted
2017-05-17 17:01:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 425 a17-13113_2425.htm 425 70844
  Complete submission text file 0001104659-17-033491.txt   72374
Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Filed by) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2150 WOODWARD ST., SUITE 100 AUSTIN TX 78744
Business Address 3711 SOUTH MOPAC EXPRESSWAY, STE 100 AUSTIN TX 78746 512-901-0900
Mirna Therapeutics, Inc. (Subject) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37566 | Film No.: 17852384
SIC: 2834 Pharmaceutical Preparations